Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

896
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
896
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

871
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
871
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

475
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
475

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metagenomic next-generation sequencing of cerebrospinal fluid reveals pathogen spectrum and mortality predictors among patients with advanced HIV-1 disease at a tertiary hospital in China.

Virology journal·2026
Same author

A preS2 aa1-26-specific humoural response marks functional cure in chronic HBV infection.

EBioMedicine·2026
Same author

APASL clinical practice guidelines on the management of chronic hepatitis B infection: a 2026 update.

Hepatology international·2026
Same author

The Fourth Symposium of Grand Challenges on HIV (2023.12.28).

Infectious diseases & immunity·2026
Same author

Impact on clinical biomarkers, immune recovery, and HIV reservoir dynamics of switching to EVG/c/FTC/TAF versus maintaining a non-INSTI-based regimen in virologically suppressed individuals.

Infectious diseases & immunity·2026
Same author

Viral persistence in long COVID: Research advances and treatment strategies.

Infectious diseases & immunity·2026
Same journal

Endoscopic techniques to minimize gastroesophageal reflux during peroral endoscopic myotomy.

Current opinion in gastroenterology·2026
Same journal

Postendoscopy esophageal adenocarcinoma and neoplasia: current status and future directions.

Current opinion in gastroenterology·2026
Same journal

The complement system in inflammatory bowel disease: from early observations to emerging frontiers.

Current opinion in gastroenterology·2026
Same journal

Goblet cell-associated antigen passages in health and disease.

Current opinion in gastroenterology·2026
Same journal

Inflammatory bowel diseases 2026: form, function and therapeutic considerations for the epithelial barrier.

Current opinion in gastroenterology·2026
Same journal

Dietary protein as a regulator of colitis and colorectal cancer.

Current opinion in gastroenterology·2026
See all related articles

Related Experiment Video

Updated: Mar 25, 2026

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
04:50

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Published on: January 17, 2025

915

Primary biliary cholangitis in China.

Lifeng Wang1, M Eric Gershwin, Fu-Sheng Wang

  • 1aResearch Center for Biological Therapy, the Institute of Translational Hepatology, Beijing 302 Hospital, Beijing, ChinabDivision of Rheumatology, Allergy and Clinical Immunology, University of California at Davis School of Medicine, Davis, California, USA.

Current Opinion in Gastroenterology
|February 18, 2016
PubMed
Summary
This summary is machine-generated.

Primary biliary cholangitis (PBC) is increasingly diagnosed in China, often without progressing to cirrhosis. Research in China is advancing diagnostics, treatments like stem cells, and understanding PBC

Related Experiment Videos

Last Updated: Mar 25, 2026

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
04:50

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Published on: January 17, 2025

915

Area of Science:

  • Hepatology and Immunology
  • Autoimmune Liver Diseases

Background:

  • Primary biliary cholangitis (PBC) is a chronic, immune-mediated liver disease targeting intrahepatic bile ducts.
  • Identification of the E2 component of the mitochondrial pyruvate dehydrogenase complex as a key autoantigen in 1987 revolutionized PBC diagnosis and research.
  • The first Chinese case was reported in 1958, with comprehensive characterization emerging in 1990.

Purpose of the Study:

  • To review the evolving landscape of Primary Biliary Cholangitis (PBC) in China.
  • To highlight advancements in understanding, diagnosing, and treating PBC within the Chinese population.
  • To discuss emerging research and therapeutic strategies originating from Chinese PBC cohorts.

Main Methods:

  • Analysis of trends in PBC diagnosis and prevalence in China.
  • Review of clinical and basic science research contributions from Chinese hepatologists and scientists.
  • Examination of novel diagnostic biomarkers and therapeutic approaches developed in China.

Main Results:

  • A significant annual increase in diagnosed PBC cases in China, potentially linked to environmental changes and improved diagnostics.
  • PBC in China is often diagnosed later but typically shows a less progressive course towards cirrhosis compared to Western cohorts.
  • Substantial Chinese contributions to PBC research, including diagnostic criteria, treatment strategies, and understanding of underlying immunological mechanisms.

Conclusions:

  • Chinese researchers are actively advancing PBC knowledge, focusing on new biomarkers and treatments.
  • Novel therapeutic avenues include stem cell therapy and traditional Chinese medicine.
  • Unique immunological insights involve the role of T-follicular helper cells and monocyte subpopulations in immune tolerance breakdown in PBC.